Sight Sciences Stock Performance
| SGHT Stock | USD 5.38 0.09 1.70% |
Risk-Adjusted Performance
0High
0 · Weak
For the recent 90-day horizon, Sight Sciences failed to convert its risk exposure into positive performance. This measure separates raw price movement from actual return efficiency on a risk-adjusted basis. Return quality for Sight Sciences sits near neutral, with recent data providing no clear directional signal for holders. Learn More
Actual Historical Performance (%)
One Day Return 1.7 | Five Day Return 22.55 | Year To Date Return -32.16 | Ten Year Return -83.94 | All Time Return -83.94 |
1 | Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 | 02/18/2026 |
2 | Disposition of 21270 shares by Badawi David of Sight Sciences at 0.23 subject to Rule 16 b-3 | 02/19/2026 |
3 | Disposition of 40000 shares by Badawi David of Sight Sciences at 0.12 subject to Rule 16 b-3 | 02/23/2026 |
4 | Sight Sciences, Inc. Receives 8.30 Average Price Target from Analysts | 03/04/2026 |
5 | Sight Sciences Q 4 Earnings Call Highlights | 03/05/2026 |
6 | Sight Sciences Price Target Cut to 11.00 by Analysts at UBS Group | 03/06/2026 |
7 | Disposition of 14418 shares by Brenton Taylor of Sight Sciences at 7.06 subject to Rule 16 b-3 | 03/19/2026 |
8 | Sight Sciences to Present at the 25 th Annual Needham Healthcare Conference on April 13 th | 03/30/2026 |
9 | Sight Sciences Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Ca... | 04/01/2026 |
10 | Disposition of 29244 shares by Paul Badawi of Sight Sciences at 3.7 subject to Rule 16 b-3 | 04/02/2026 |
11 | Disposition of 13761 shares by Jeremy Hayden of Sight Sciences at 3.55 subject to Rule 16 b-3 | 04/06/2026 |
12 | Analysts Set Sight Sciences, Inc. Price Target at 8.31 | 04/23/2026 |
13 | Disposition of 594 shares by James Rodberg of Sight Sciences at 7.48 subject to Rule 16 b-3 | 05/05/2026 |
14 | Sight Sciences GAAP EPS of -0.24 misses by 0.07, revenue of 19.7 M beats by 1.15 M | 05/06/2026 |
15 | Sight Sciences Releases Quarterly Earnings Results, Misses Estimates By 0.05 EPS | 05/08/2026 |
Performance Related Modules
Relative Risk vs. Return Landscape
If you had invested $ 594.00 in Sight Sciences on February 9, 2026 and sold it today, you would have lost $ 56.00 , a decline of 9.43% over 90 days. Sight Sciences is currently generating a 0.0283% daily expected return and carries 5.99% risk (volatility on return distribution) over a 90-day horizon. In relative terms, Sight Sciences exhibits above-average volatility, exceeding roughly 47% of comparable stocks, and SGHT has trailed 99% of traded instruments in return over the 90-day horizon. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
Market participants occasionally evaluate whether Sight Sciences Stock is trading materially outside its longer-term historical range. Sustained premiums or discounts can occur when investors reassess growth expectations, risk exposure, or macroeconomic conditions. For volatile assets, pricing behavior may reflect changing expectations more than historical valuation anchors.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 5.38 | 90 days | 5.38 | about 11.51 % |
Probability analysis for this stock suggests that the odds of Sight Sciences moving above the current price in 90 days from now are about 11.51 %. Recent return data has shown a distribution that skews above the current level over this window. (This density function focuses attention on the most probable trading range for Sight Sciences Stock over the next 90 days).
Sight Sciences Price Density |
| Price |
Predictive Modules for Sight Sciences
The challenge of forecasting Sight Sciences mirrors the broader difficulty of predicting stock market movements. While perfect accuracy is unattainable, applying multiple models remains a core part of sound stock analysis. Market surprises are inevitable, but disciplined forecasting still improves investment decision-making.The mean reversion effect in Sight Sciences is stronger when the initial deviation was driven by sentiment rather than fundamentals. Such deviations have sometimes corrected when the initial catalyst fades, though timing remains uncertain. The degree to which Sight Sciences' exhibits mean reversion depends on how efficiently the market prices new information.
Primary Risk Indicators
Over recent decades, the stock market has seen multiple large corrections and recoveries affecting Sight Sciences. Both sharp declines and powerful rallies have tested investor discipline in Sight Sciences. Tracking Sight Sciences' volatility and fundamental risk indicators provides a framework for managing downside exposure.α | Alpha over Dow Jones | -0.0181 | |
β | Beta against Dow Jones | 2.30 | |
σ | Overall volatility | 0.80 | |
Ir | Information ratio | -0.0035 |
Investor Alerts and Insights
Investors who use alerts for Sight Sciences can respond more quickly to important stock events. Checking Sight Sciences notifications regularly is a straightforward way to stay on top of actionable developments. Combining Sight Sciences alerts with broader market context improves the quality of investment decisions.| Sight Sciences had very high historical volatility over the last 90 days | |
| Sight Sciences has high likelihood to experience some financial distress in the next 2 years | |
| SGHT reported previous year's revenue of $77.36 million. Net Loss for the year was -$38.43 million with profit before overhead, payroll, taxes, and interest of $68.55 million. | |
| Sight Sciences currently holds about $220.1 million in cash as of latest reporting with -$29.69 million of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6. | |
| Sight Sciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 20.0% of SGHT outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: Sight Sciences Releases Quarterly Earnings Results, Misses Estimates By 0.05 EPS |
Price Density Drivers
For investors analyzing Sight Sciences, understanding buyer and seller positioning dynamics is essential for price analysis. Monitoring these dynamics helps anticipate short-term price movements and gauge current market conditions. Assessing Sight Sciences' price density drivers indicates whether recent moves are fundamental or tactical.
| Common Stock Shares Outstanding | 52.15 million | |
| Cash And Short Term Investments | 91.97 million |
Sight Sciences Fundamentals Growth
The market value of Sight Sciences Stock depends on how investors perceive Sight Sciences' financial strength. Earnings growth, revenue momentum, profitability ratios, and debt levels drive Sight Sciences Stock valuation. The financial health of Sight Sciences is the primary driver of Sight Sciences Stock market performance over time.
| Current Valuation | 178.94 M | |||
| Shares Outstanding | 54.41 M | |||
| Earnings Per Share | -0.70 X | |||
Performance Metrics & Calculation Methodology
Drawdown analysis for Sight Sciences measures how deep losses have been and how long recovery has taken historically. Recovery duration matters as much as drawdown depth in the context of analysis of performance resilience. Sight Sciences shows ROE of -56.64%, ROA of -17.16% (TTM) vs -35.0% (last reported).
Reported values for Sight Sciences are derived from periodic company reporting and market reference feeds and standardized for analysis. Analyst projections are included when active coverage applies. Return and risk statistics are calculated from historical price series.
Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board